Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Soubrane

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Presse Medicale (Paris, France : 1983)|February 5, 1994
[Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients]J Suissa, C Hoang, C Soubrane, et al.
Gene Therapy|June 1, 1996
Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free systemA M Ghoumari, O Rixe, S V Yarovoi, et al.
American Journal of Nephrology|January 1, 1986
Influence of the uremic state on the development of malignancy. An experimental study in the ratC Soubrane, C Jacobs, C Jacquillat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1989
[Q fever infectious endocarditis. Apropos of a new case]C Soubrane, M Bellorini, J Granier, et al.
Revue Des Maladies Respiratoires|January 1, 1984
[Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer]G Decroix, C Chastang, B Lebeau, et al.
Clinical and Experimental Immunology|February 1, 1994
Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapyC Soubrane, R Mouawad, M Ichen, et al.
Melanoma Research|December 1, 1995
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patientsO Rixe, C Borel, D Paraiso, et al.
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
La Revue De Medecine Interne|March 21, 2009
[Anticoagulation clinics for outpatients: a 5-year experience]Y Benhamou, V Le Cam-Duchez, J-M Schneller, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanomaE C Antoine, O Rixe, E Vuillemin, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Presse Medicale (Paris, France : 1983)|February 5, 1994
[Flow cytometry of thyroid tumors. Study of fresh tissue in 50 patients]J Suissa, C Hoang, C Soubrane, et al.
Gene Therapy|June 1, 1996
Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free systemA M Ghoumari, O Rixe, S V Yarovoi, et al.
American Journal of Nephrology|January 1, 1986
Influence of the uremic state on the development of malignancy. An experimental study in the ratC Soubrane, C Jacobs, C Jacquillat, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1989
[Q fever infectious endocarditis. Apropos of a new case]C Soubrane, M Bellorini, J Granier, et al.
Revue Des Maladies Respiratoires|January 1, 1984
[Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer]G Decroix, C Chastang, B Lebeau, et al.
Clinical and Experimental Immunology|February 1, 1994
Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapyC Soubrane, R Mouawad, M Ichen, et al.
Melanoma Research|December 1, 1995
Fotemustine, dacarbazine, vindesine combination chemotherapy in advanced malignant melanoma: a phase II study of 43 patientsO Rixe, C Borel, D Paraiso, et al.
The Journal of Infectious Diseases|March 1, 1990
Changes of soluble CD16 levels in serum of HIV-infected patients: correlation with clinical and biologic prognostic factorsD Khayat, C Soubrane, J M Andrieu, et al.
La Revue De Medecine Interne|March 21, 2009
[Anticoagulation clinics for outpatients: a 5-year experience]Y Benhamou, V Le Cam-Duchez, J-M Schneller, et al.
American Journal of Clinical Oncology|October 1, 1995
A phase II study of tamoxifen combined with cisplatin-interleukin 2 and alpha-interferon in metastatic melanomaE C Antoine, O Rixe, E Vuillemin, et al.
Pageof 6